Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Plos One|June 6, 2012
BRCA2 mutations and triple-negative breast cancerPeter Meyer, Katharina Landgraf, Bernhard Högel, et al.
Oncotargets and Therapy|October 23, 2014
PTK7 as a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients, and resistance to anthracycline drugsBeyhan Ataseven, Angela Gunesch, Wolfgang Eiermann, et al.
Anticancer Research|September 12, 2013
PTK7 expression in triple-negative breast cancerBeyhan Ataseven, Regina Angerer, Ronald Kates, et al.
BMC Cancer|April 20, 2013
Monocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activatorPhilip Vlaicu, Philipp Mertins, Thomas Mayr, et al.
Plos One|January 11, 2014
PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvementSilvia Gärtner, Angela Gunesch, Tatiana Knyazeva, et al.
Breast Cancer Research and Treatment|August 11, 2010
Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio studyJens Huober, Gunter von Minckwitz, Carsten Denkert, et al.
BMC Cancer|July 30, 2014
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypesSilvia Darb-Esfahani, Gunter von Minckwitz, Carsten Denkert, et al.
Pageof 1